Medical Patent News

RSS
New national guidelines for anal cancer prevention in HIV patients based on UCSF research

New national guidelines for anal cancer prevention in HIV patients based on UCSF research

Transgender people face challenges getting needed care

Transgender people face challenges getting needed care

UNF researchers awarded U.S. patent for targeted cancer-fighting compound

UNF researchers awarded U.S. patent for targeted cancer-fighting compound

Non-invasive blood test shows 83% sensitivity in detecting colorectal cancer, offering hope for early diagnosis

Non-invasive blood test shows 83% sensitivity in detecting colorectal cancer, offering hope for early diagnosis

Bio-Techne to present at the KeyBanc Life Sciences & MedTech Investor Forum

Bio-Techne to present at the KeyBanc Life Sciences & MedTech Investor Forum

U.S. patent granted for novel tool designed to reliably diagnose and monitor sickle cell disease

U.S. patent granted for novel tool designed to reliably diagnose and monitor sickle cell disease

Cellular Origins Launches Constellation, its Configurable Robotic Platform to Enable Scalable Manufacture of Advanced Therapies

Cellular Origins Launches Constellation, its Configurable Robotic Platform to Enable Scalable Manufacture of Advanced Therapies

Impaired glucose tolerance and cardiovascular risk factors associated with fertility problems

Impaired glucose tolerance and cardiovascular risk factors associated with fertility problems

Metformin use associated with lower risk of joint replacement in people with type 2 diabetes

Metformin use associated with lower risk of joint replacement in people with type 2 diabetes

FIU researchers awarded a U.S. patent for devising methods to synthesize new arsenic-based antibiotic

FIU researchers awarded a U.S. patent for devising methods to synthesize new arsenic-based antibiotic

LSU Health New Orleans to receive patent for a noninvasive test to diagnose fatal condition in preemies

LSU Health New Orleans to receive patent for a noninvasive test to diagnose fatal condition in preemies

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

New statement assesses the legal hurdles of patent waiver proposal for Covid-19 vaccines

New statement assesses the legal hurdles of patent waiver proposal for Covid-19 vaccines

World's first patent for AI-generated invention could have repercussions on intellectual property law

World's first patent for AI-generated invention could have repercussions on intellectual property law

Study provides renewed hope for treating Alzheimer's and Parkinson's diseases

Study provides renewed hope for treating Alzheimer's and Parkinson's diseases

GenScript and Duke-NUS announce notice of allowance for “Surrogate Virus Neutralization Technology”

GenScript and Duke-NUS announce notice of allowance for “Surrogate Virus Neutralization Technology”

ERS Genomics and genOway enter CRISPR/Cas9 agreement

ERS Genomics and genOway enter CRISPR/Cas9 agreement

STEMI patients with multi-vessel disease have no benefit from FFR-guided PCI

STEMI patients with multi-vessel disease have no benefit from FFR-guided PCI

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

New double-balloon catheter receives Canadian patent

New double-balloon catheter receives Canadian patent

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.